Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy

Abstract Introduction Although patients with HBV have a risk of reactivation after immunosuppressive therapy (IST), the status of their risk management is unclear in Japan. This study aims to describe the proportion of patients who received preventive management of HBV reactivation during ISTs in pa...

Full description

Bibliographic Details

Published in:	Infectious Diseases and Therapy
Main Authors:	Yasuhito Tanaka, Daisuke Nakamoto, Yi Piao, Hajime Mizutani, Ryozo Wakabayashi, Yoshiyuki Saito, Kyung min Kwon, Harriet Dickinson
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2024-05-01
Subjects:	HBV infection HBV reactivation management Immunosuppressive therapy
Online Access:	https://doi.org/10.1007/s40121-024-00997-0